Showing 1741-1750 of 3070 results for "".
- Ultrasound Elastography Tracks Reversible Masseter Remodeling After BoNT-A Injectionshttps://modernaesthetics.com/news/ultrasound-elastography-tracks-reversible-masseter-remodeling-after-bont-a-injections/2484690/Botulinum neurotoxin type A (BoNT-A) induces reversible changes in both masseter volume and elasticity, according to a new prospective study using ultrasound elastography (USE) to quantify structural adaptation post-injection. The findings, published ahead of print
- ODAC 2026 Adds Hands-On, High-Impact Workshopshttps://modernaesthetics.com/news/odac-2026-adds-hands-on-high-impact-workshops/2484689/The ODAC Dermatology Conference will return to Orlando, Florida, in 2026 with a refreshed slate of interactive, expert-led sessions that emphasize skill-building across medical, surgical, and aesthetic dermatology, organizers said in a press release. Scheduled for J
- AI-Guided Ultrasound Enhances Safety of Thread Lifting with Energy-Based Deviceshttps://modernaesthetics.com/news/ai-guided-ultrasound-enhances-safety-of-thread-lifting-with-energy-based-devices/2484656/Thread lifting using poly-L-lactic acid (PLLA) and polycaprolactone (PCL) sutures appears to be safe when performed under artificial intelligence (AI)-guided high-frequency ultrasound—even when combined with energy-based modalities on the same day, according to a new retrospective study published
- RVL Pharmaceuticals Announces New CEO, Chief Growth Officerhttps://modernaesthetics.com/news/rvl-pharmaceuticals-announces-new-ceo-chief-growth-officer/2484615/RVL Pharmaceuticals, Inc. has appointed Lori Deo as Chief Executive Officer and Amy Shah as Chief Growth Officer, signaling a strategic leadership shift aimed at accelerating growth for its lead product, Upneeq (oxymetazoline hydrochloride ophthalmic solution), 0.1%. Deo, who previously se
- Lumenis Debuts Stellar M22™ with XPL™ at ASDS 2025, Showcases Single-Session Clearance Datahttps://modernaesthetics.com/news/lumenis-debuts-stellar-m22-with-xpl-at-asds-2025-showcases-single-session-clearance-data/2484554/Lumenis Be. Ltd. introduced the next-generation Stellar M22™ with XPL™ Technology during the 2025 Annual American Society for Dermatologic Surgery (ASDS) Meeting, highlighting single-session clearance rates of up to 100% for vascular and pigmented lesions. The multi-application aesthetic platform
- Skin of Color Society Media Day Analyzes Latest Trendshttps://modernaesthetics.com/news/skin-of-color-society-media-day-analyzes-latest-trends/2484533/In an era of misinformation and viral skincare fads, the Skin of Color Society’s (SOCS) 8th Annual Media Day offered a timely and authoritative voice, gathering top board-certified dermatologists to address critical dermatologic topics relevant to patients with skin of color. From trending TikTok
- Allergan Aesthetics Celebrates Seventh Annual BOTOX® Cosmetic Dayhttps://modernaesthetics.com/news/allergan-aesthetics-celebrates-seventh-annual-botox-cosmetic-day/2484512/Allergan Aesthetics, an AbbVie company, marks the seventh annual BOTOX® Cosmetic Day on Wednesday, November 19, 2025. The yearly celebration honors patients and providers who have contributed to the longevity and success of the injectable treatment, which remains the top-selling product in its ca
- Pluri Launches Regenerative Aesthetics Subsidiary Cellav in Collaboration with Miss Universe Skincarehttps://modernaesthetics.com/news/pluri-launches-regenerative-aesthetics-subsidiary-cellav-in-collaboration-with-miss-universe-skincare/2484496/Pluri Inc. has launched Cellav Health and Aesthetics Ltd., focused on science-based regenerative skincare. The company announced a strategic collaboration with Miss Universe Skincare to co-develop a new line of cell-based skincare products.
- AAFPRS Forecasts Regeneration, Precision, and Personalization as Defining Aesthetic Trends for 2026https://modernaesthetics.com/news/aafprs-forecasts-regeneration-precision-and-personalization-as-defining-aesthetic-trends-for-2026/2484425/Aesthetic medicine is rapidly evolving beyond enhancement and rejuvenation, moving toward regenerative, precision-driven care tailored to the individual. The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) has released its annual aesthetic trend forecast, highlighting the t
- FDA Clears Ultherapy PRIME for Skin Laxity on Arms, Abdomenhttps://modernaesthetics.com/news/fda-clears-ultherapy-prime-for-skin-laxity-on-arms-abdomen/2484325/The US Food and Drug Administration (FDA) has cleared Ultherapy PRIME for the treatment of skin laxity on the anterior arms, posterior arms, and abdomen, according to Merz Aesthetics. The device is now FDA-cleared for noninvasive lifting and firming of the face, neck, décolleté, and body.